Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin

ClinicalTrials.gov ID: NCT00630877

Public ClinicalTrials.gov record NCT00630877. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Parallel, Multicenter, Placebo-controlled, Prospective Study to Evaluate the Functionality of the Flushing ASsessment Tool (FAST) in Subjects Administered Niaspan® Plus Acetylsalicylic Acid (ASA), Niaspan® Plus ASA Placebo or Niaspan® Placebo Plus ASA Placebo Daily for Six Weeks

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study was to evaluate the psychometric characteristics (reliability, validity, and responsiveness) of a Flushing ASsessment Tool (FAST) in subjects receiving niacin extended-release (NER) plus aspirin (ASA) daily for 6 weeks. The FAST is a questionnaire that was developed to provide a detailed assessment of flushing symptoms and their impact in patients receiving niacin therapy. The effect of aspirin on flushing symptoms, as measured by the FAST, was also evaluated.

Study identification

NCT ID
NCT00630877
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
276 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2008 (Type not available)
Primary completion
Jun 2008 (Actual)
Completion
Jun 2008 (Actual)
Last update posted
Oct 9, 2009

2008

United States locations

U.S. sites
40
U.S. states
18
U.S. cities
38
Facility City State ZIP Site status
Not listed Birmingham Alabama 35209 —
Not listed Anaheim California 92801 —
Not listed Walnut Creek California 94598 —
Not listed Denver Colorado 80212 —
Not listed Brooksville Florida 34613 —
Not listed Daytona Beach Florida 32127 —
Not listed Hollywood Florida 33023 —
Not listed Jacksonville Florida 32216 —
Not listed Largo Florida 33770 —
Not listed Miami Florida 33126 —
Not listed Pembroke Pines Florida 33026 —
Not listed Boise Idaho 83704 —
Not listed Chicago Illinois 60610 —
Not listed Arkansas City Kansas 67005 —
Not listed Topeka Kansas 66608 —
Not listed Wichita Kansas 67203 —
Not listed Wichita Kansas 67207 —
Not listed St Louis Missouri 63141 —
Not listed Las Vegas Nevada 89146 —
Not listed Durham North Carolina 27704 —
Not listed High Point North Carolina 27262 —
Not listed Salisbury North Carolina 28144 —
Not listed Statesville North Carolina 28677 —
Not listed Cincinnati Ohio 45242 —
Not listed Portland Oregon 97239 —
Not listed Duncansville Pennsylvania 16635 —
Not listed Harleysville Pennsylvania 19438 —
Not listed Pittsburgh Pennsylvania 15206 —
Not listed Greer South Carolina 29651 —
Not listed Austin Texas 78752 —
Not listed Carrollton Texas 75006 —
Not listed Dallas Texas 75251 —
Not listed San Antonio Texas 78217 —
Not listed San Antonio Texas 78224 —
Not listed Magna Utah 84044 —
Not listed Murray Utah 84107 —
Not listed Sandy City Utah 84094 —
Not listed Gig Harbor Washington 98335 —
Not listed Menomonee Falls Wisconsin 53051 —
Not listed Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00630877, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 9, 2009 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00630877 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →